Takeda Fellowships
Takeda Pharmaceuticals, in collaboration with MCPHS, offers unique fellowships to elevate the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. Fellows gain extensive experience through various practical activities in both industry and academic settings, which will enhance the potential for accelerated career development. The following options are offered by Takeda in conjunction with MCPHS:
- Global Clinical Supply Chain - recruiting for 1 position (2027-2029)
- Patient Safety and Pharmacovigilance (not recruiting for 2027 - 2029 cycle)
- Global Scientific Communications (not recruiting for 2027 - 2029 cycle)
Please see our brochure for additional details.
About Takeda Pharmaceuticals
Founded in 1781, Takeda is a patient-focused, values-based, research and development (R&D)-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 245-year history in Japan. At the U.S. headquarters for Takeda, three of our seven global manufacturing site are centered in Massachusetts enabling us to build relationships with cutting-edge companies, academic institutions, scientists and organizations who join us in the effort to discover, develop, and deliver new treatments to patients. We have several locations across the greater Boston area. As an R&D-driven organization, Takeda has state-of-the-art facilities to help advance the next generation of innovation, and Takeda’s pharmaceutical products are marketed globally. The company has grown in size and scope both organically and through acquisition. Takeda-ism (our values of Integrity, Fairness, Honesty, and Perseverance) grounds us as we deliver on our role to serve the public by ensuring integrity in our every action for and on behalf of patients.
Our R&D efforts are focused on adapting to an evolving landscape, strengthening our research engine, focusing on what sets us apart, and working together to deliver life-transforming medicines for rare and more prevalent diseases across three areas: Oncology, Neuroscience and Gastrointestinal and Inflammation. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. By embedding data, digital and technology across research and development, we will deliver our new medicines to patients faster. We are developing highly innovative medicines that contribute to making a difference in patient’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.